SCHEMBL13985802

SCHEMBL13985802

O=C(OCCN(Cc1ccccc1)Cc1ccccc1)N1CCC(n2c(=O)n(CC3CCCCC3)c3ccccc32)CC1

nearest known ligand 0.48

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ OPRL1 P41146 8/20 0.48
▸ OPRM1 P35372 5/20 0.48
▸ OPRK1 P41145 1/20 0.48
▸ ENPP2 Q13822 1/20 0.46
▸ CACNA1G O43497 2/20 0.44
▸ CACNA1H O95180 2/20 0.44
▸ CYP2D6 P10635 4/20 0.42
▸ CYP3A4 P08684 4/20 0.42
▸ C5AR1 P21730 2/20 0.39
▸ CHRM4 P08173 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13985782 0.85 CACNA1G (0.42) OPRL1OPRM1CACNA1GCACNA1HCYP2D6
SCHEMBL3748470 0.84 OPRL1 (0.48) OPRL1OPRM1OPRK1ENPP2CACNA1G
SCHEMBL3748474 0.84 OPRL1 (0.48) OPRL1OPRM1OPRK1ENPP2CACNA1G
SCHEMBL13985723 0.83 CYP3A4 (0.48) CACNA1GCACNA1HCYP2D6CYP3A4C5AR1
SCHEMBL13985781 0.83 DRD2 (0.42) CACNA1GCACNA1HCYP2D6CYP3A4C5AR1
SCHEMBL13985629 0.82 ALDH1A1 (0.43) CACNA1GCACNA1HCYP2D6CYP3A4C5AR1
SCHEMBL13980436 0.81 CACNA1G (0.40) CACNA1GCACNA1HCYP2D6CYP3A4CHRM4
SCHEMBL4678737 0.80 OPRL1 (0.63) OPRL1OPRM1OPRK1ENPP2CACNA1G
SCHEMBL13985630 0.80 ALDH1A1 (0.40) CACNA1GCACNA1HCYP2D6CYP3A4CHRM4
SCHEMBL13985721 0.80 ALDH1A1 (0.40) CACNA1GCACNA1HCYP2D6CYP3A4C5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback